Stay updated on Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Sign up to get notified when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.

Latest updates to the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMinor site-wide updates were made, including adding revision v3.4.2 and removing notices about funding lapse and revision v3.4.1. These changes do not affect study data, eligibility, or user actions on the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding lapse notice with operating status details and updated the site version to Revision: v3.4.1, removing the previous v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedThese changes are UI/text updates: Show glossary was added; the Last Update Submitted that Met QC Criteria label was introduced; No FEAR Act data capitalization changed; and the revision now displays v3.4.0, with no modifications to core study data, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded a new publication entry for the EMBARK trial: Mendell JR et al., Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial (Neurol Ther. 2026 Jan 10; online ahead of print). Page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedLocation list updated: new sites added across multiple US states and international locations; several previously listed locations were removed.SummaryDifference2%

- Check92 days agoChange Detected- Added clarifications about how publications are displayed (voluntary input and PubMed auto-fill) and updated the page revision to v3.3.2. - Removed older wording about publications and PubMed data sources, and the v3.2.0 revision note.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Delandistrogene in Duchenne Muscular Dystrophy page.